FEM CARE PHARMA: SYNERGISTIC BUT COSTLY BUY FOR DABUR

摘要

Dabur India's all-cash deal to acquire Fern Care Pharma for Rs 203.7 crore may bring in brands which are complemen-tary to Dabur's own in the personal care space and manufacturing facilities that allow it to expand its product basket. But the acquisition appears expensive in the context of Fern Care's financials.